Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGFBR1 | P36897 | 17/20 | 0.45 |
| ▸ | MMP13 | P45452 | 1/20 | 0.41 |
| ▸ | F2 | P00734 | 1/20 | 0.40 |
| ▸ | F10 | P00742 | 1/20 | 0.40 |
| ▸ | PLG | P00747 | 1/20 | 0.40 |
| ▸ | PLAU | P00749 | 1/20 | 0.40 |
| ▸ | ST14 | Q9Y5Y6 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7951214 | 0.94 | TGFBR1 (0.44) | TGFBR1MMP13 | |
| SCHEMBL6969887 | 0.94 | TGFBR1 (0.49) | TGFBR1MMP13F2F10PLG | |
| SCHEMBL7943420 | 0.93 | TGFBR1 (0.47) | TGFBR1F2 | |
| SCHEMBL6964258 | 0.92 | MMP13 (0.50) | TGFBR1MMP13 | |
| SCHEMBL7951844 | 0.92 | ALDH1A1 (0.44) | TGFBR1MMP13 | |
| SCHEMBL6976329 | 0.91 | F2 (0.44) | TGFBR1MMP13F2F10PLG | |
| SCHEMBL6962633 | 0.91 | MMP13 (0.49) | TGFBR1MMP13 | |
| SCHEMBL6964185 | 0.90 | GPR119 (0.48) | MMP13 | |
| SCHEMBL6973611 | 0.90 | GAA (0.41) | TGFBR1MMP13F2F10PLG | |
| SCHEMBL6963385 | 0.90 | STS (0.46) | MMP13MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1098878-B1 | BISPIPERIDINES AS ANTITHROMBOTIC AGENTS | CEPHALON FRANCE (FR) | 2003-12-17 | — | — | EP | disclosed |
| US-6333338-B1 | ANTICOAGULANTS, CARDIOVASCULAR DISORDERS | LABORATOIRE L. LAFON (FR) | 2001-12-25 | — | — | US | disclosed |